KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Shares Outstanding (Diluted Average) (2016 - 2026)

Bio-Rad Laboratories has reported Shares Outstanding (Diluted Average) over the past 18 years, most recently at $27.0 million for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) fell 3.57% to $27.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $27.0 million through Mar 2026, down 3.57% year-over-year, with the annual reading at $27.3 million for FY2025, 3.31% down from the prior year.
  • Shares Outstanding (Diluted Average) was $27.0 million for Q1 2026 at Bio-Rad Laboratories, down from $27.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $29.9 million in Q1 2022 and troughed at $27.0 million in Q1 2026.
  • The 5-year median for Shares Outstanding (Diluted Average) is $28.5 million (2024), against an average of $28.7 million.
  • Year-over-year, Shares Outstanding (Diluted Average) decreased 0.62% in 2023 and then dropped 4.07% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $29.8 million in 2022, then dropped by 1.93% to $29.2 million in 2023, then dropped by 3.41% to $28.2 million in 2024, then dropped by 3.31% to $27.3 million in 2025, then fell by 1.18% to $27.0 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Shares Outstanding (Diluted Average) are $27.0 million (Q1 2026), $27.3 million (Q4 2025), and $27.4 million (Q3 2025).